About 200 reports

  • Biosimilars Versus Interchangeable Biosimilars
  • What Is a Biosimilar?

Biosimilars in Oncology Summary Recent trends in drug development have seen the price of new medicines continually increase, and there is a need for cheaper medicines to achieve global sustainable healthcare.Biologic drugs are some of the most expensive medicines to develop, as they are large complex...

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • US Approved Biosimilars
  • 3.3.2 Major Biosimilars in the Pipeline

Scope of the Report The report entitled “Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)”, provides an analysis of global biosimilar market in terms of value. The report also provides a brief analysis of the global biologics market by value and market share by products. Furthermore, the report also assesses...

  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • BIOSIMILARS
  • Biosimilar Process

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Summary Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. A...

  • Biosimilar
  • Therapy
  • World
  • Supply
  • Remicade group

ZYDUS CADILA Chapter ## Appendix: Abbreviations List of Tables Summary Table : Global Market for Biosimilars, by Type, Through 2022 Table ## : List of Biosimilars Produced in E.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Pharmaceutical
  • World

Global Biosimilars Partnering 2010-2018 Executive Summary Chapter ## – Introduction Chapter ## – Trends in Biosimilars dealmaking ##. ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Demand
  • 6.8.1 REIMBURSEMENT OF BIOSIMILARS IN UNITED KINGDOM
  • 11.3 BIOSIMILARS MANUFACTURING CHALLENGES

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Biosimilars
  • Concerns with biosimilars

Physician Perspectives 2017: Biosimilar use in IBD Summary This Physician Perspectives survey focuses on the use of biosimilar anti-TNFs in IBD. In the next 12 months, nearly half of physicians stated that they would consider switching Remicade patients (in remission) over to biosimilar IFX.A...

  • Biosimilar
  • Health Care Provider
  • Monoclonal Antibody
  • United States
  • Remicade group
  • Biosimilars: Overview
  • Emergence of biosimilars

About Biosimilars Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product....

  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Sandoz Inc.
  • Teva Pharmaceuticals Ltd.

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Biosimilar
  • Therapy
  • World
  • Market Shares
  • Market Size

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biosimilar
  • Oncology
  • APAC
  • World
  • Market Size

Global Biosimilars and Follow-On Biologics Market 2017-2027 ##.

  • Biopharmaceutical
  • Biosimilar
  • World
  • Market Shares
  • Market Size
  • Emergence of biosimilars
  • Biosimilars industry

About Oncology Biosimilars Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting....

  • Biosimilar
  • Biocon Limited
  • Celltrion, Inc.
  • Hospira, Inc.
  • Sandoz Inc.

Commercialisaton of Biosimilars: Multifunctional teamwork for success ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World

Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 ## Preface ## Scope and Methodology ##. ## Objectives of the Study ##. ## Stakeholders ##. ## Data Sources ##. ##. ## Primary Sources ##. ##. ## Secondary Sources ##. ## Market Estimation ##. ##. ## Bottom-Up App

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

Biosimilars: EU Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Pharmaceutical
  • Europe

Physician reluctance to use biosimilars interchangeably with the original product may prove to be an issue, albeit one that can be overcome with education efforts.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Forecast

Global Biosimilar Market Outlook 2022 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

APAC Biosimilar Market, Forecast 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Therapy
  • Market Size

You can request one free hour of our analyst’s time when you purchase this market report.

  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • World
  • Market Size

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022 ##.

  • Biosimilar
  • Insulin
  • Pathology
  • World
  • Market Size

PHARMA LEADER SERIES: ## TOP BIOSIMILAR DRUG MANUFACTURERS 2017-2027 ##.

  • Biopharmaceutical
  • Biosimilar
  • China
  • Company
  • Market Size

The Future of Biosimilars in the USA: Mapping critical uncertainties and the impact of future events ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Market Size

Biosimilars: US Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Therapy
  • United States

Biosimilars Market, Europe, Forecast to 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • Forecast

It’s no secret that launching biosimilars into emerging markets is a growth opportunity, but this is one area where it really does pay to look before you leap.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • India

Biosimilars Market Access in the EU EXECUTIVE SUMMARY A regulatory pathway governing biosimilars in Europe has existed for over a decade Biosimilar developers need to overcome a plethora of IP and legal obstacles Biosimilar naming and labeling in the EU is uniform

  • Biosimilar
  • Europe
  • European Union
  • Italy
  • United Kingdom

Biosimilars: European Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • European Union

Biosimilars Education: Addressing a significant unmet need ##.

  • Biopharmaceutical
  • Biosimilar
  • European Union
  • United States
  • World